Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
While tinkering with genetics might sound like something out of a science-fiction thriller, some companies are actually using it to create life-changing treatments.
And our best tech stock to buy today comes from this groundbreaking new industry.
The company we're talking about specializes in next-generation sequencing (NGS), which refers to the accurate, rapid, and affordable analysis of genomes. This a new development in the world of DNA manipulation and a substantial upgrade from what first-generation sequencing did.
Fred Sanger created first-generation sequencing when he mapped the whole DNA genome in 1977. Since then, the Human Genome Project has been ongoing, and advances in technology have created automatic sequencing machines and greater potential to use genetics to address some of the most complex issues of our time.
Scientists in September were able to use newly developed methods to alter the genetics of the offspring of common pigeons. They inserted the DNA of the passenger pigeons, which effectively brought back a species that had become extinct in 1914.
But the NGS technology has even more profound possibilities for us. The idea is that this type of technology can help eliminate and cure diseases like Alzheimer's and even cancer.
Critical: A breakthrough technology could disrupt every major industry, and one tiny company is at the center of it all. Its stock is trading for less than $10 now, but could deliver a 471.9% gain for early investors. Learn more…
That also means it has incredible profit potential for investors who know which gene-editing stocks to buy. In fact, by investing in this technology, you aren't just making money, you're helping develop life-saving treatments.
In 2015, the NGS market had a value of $4.62 billion. Grand View Research expects that figure to skyrocket to $21.4 billion by 2025, a gain of 362%.
And to help you find the best tech stock to buy in this exciting new space, we've turned to an expert.
Money Morning Defense and Tech Specialist Michael Robinson boasts 30 years' experience in the tech industry and has a Rolodex packed with Silicon Valley CEO contacts.
With the NGS market having triple-digit projected growth over the next seven years, Robinson advises that investors can take advantage of this booming market with one top tech stock that has the potential to double in value…